Collection of Pharmacokinetic Samples From People With Unanticipated Response, Significant Toxicity or Concern of Future Toxicity
Enrolling by invitationOBSERVATIONAL
Enrollment
100
Participants
Timeline
Start Date
July 31, 2014
Primary Completion Date
May 1, 2029
Study Completion Date
May 1, 2030
Conditions
CancerSolid TumorsNeoplasm
Trial Locations (1)
20892
National Institutes of Health Clinical Center, Bethesda
All Listed Sponsors
lead
National Cancer Institute (NCI)
NIH
NCT02154022 - Collection of Pharmacokinetic Samples From People With Unanticipated Response, Significant Toxicity or Concern of Future Toxicity | Biotech Hunter | Biotech Hunter